Imbalances in circulating lymphocyte subsets in Hu antibody associated paraneoplastic neurological syndromes

被引:6
|
作者
de Beukelaar, J. W.
Smitt, P. A. Sillevis
Hop, W. C.
Kraan, J.
Hooijkaas, H.
Verjans, G. M. G. M.
Gratama, J. W.
机构
[1] Erasmus Univ, Ctr Med, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands
[2] Erasmus Univ, Ctr Med, Dept Neurol, NL-3075 EA Rotterdam, Netherlands
[3] Erasmus Univ, Ctr Med, Dept Epidemiol & Biostat, NL-3075 EA Rotterdam, Netherlands
[4] Erasmus Univ, Ctr Med, Dept Immunol, NL-3075 EA Rotterdam, Netherlands
[5] Erasmus Univ, Ctr Med, Dept Virol, NL-3075 EA Rotterdam, Netherlands
关键词
Hu antibodies; immune phenotype; paraneoplastic syndrome; small cell lung cancer; T lymphocytes;
D O I
10.1111/j.1468-1331.2007.01986.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In paraneoplastic neurological syndromes (PNS) associated with small cell lung cancer (SCLC) and Hu antibodies, neuron-specific Hu antigens expressed by the tumour hypothetically trigger an immune response that cross-reacts with Hu antigens in the nervous system, resulting in tumour suppression and neuronal damage. To gain more insight into the hypothesized cell-mediated immune pathogenesis of these syndromes, we analysed the circulating lymphocyte subsets in untreated patients with SCLC, PNS and Hu antibodies (n = 18), SCLC without PNS (n = 19) and controls (n = 29) using flow cytometry. SCLC patients with PNS had a variety of imbalances within their circulating lymphocyte subsets as compared with SCLC patients without PNS and healthy controls: (i) a lymphopenia of the major subsets (i.e. B, CD4(+) and CD8(+) T lymphocytes); (ii) increased proportions of activated CD4(+) and CD8(+) T cells; (iii) reduced numbers of terminally differentiated effector CD8(+) T cells and cells with a cytotoxic T-cell phenotype (CD56(+) and CD57(+)). Although indirect, our data provide further support for the involvement of T cells in the pathogenesis of Hu antibody associated PNS.
引用
收藏
页码:1383 / 1391
页数:9
相关论文
共 50 条
  • [21] Antibody types and IgG subclasses in paraneoplastic neurological syndromes
    Greenlee, JE
    Boyden, JW
    Pingree, M
    Brashear, HR
    Clawson, SA
    Keeney, PM
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 184 (02) : 131 - 137
  • [22] Genetic alterations in tumors and immune tolerance breackdown in anti-hu associated paraneoplastic neurological syndromes
    Pegat, Antoine
    Vogrig, Alberto
    Honnorat, Jerome
    Attignon, Valery
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 : S9 - S9
  • [23] HLA-DQ2+ individuals are susceptible to Hu-Ab associated paraneoplastic neurological syndromes
    de Graaf, Marieke T.
    de Beukelaar, Janet W. K.
    Haasnoot, Geert W.
    Levering, Wilfried H. B. M.
    Rogemond, Veronique
    Didelot, Adrien
    Honnorat, Jerome
    Gratama, Jan W.
    Smitt, Peter A. E. Sillevis
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 226 (1-2) : 147 - 149
  • [24] Various clinical features of patients with anti-Hu associated paraneoplastic neurological syndromes: An observational study
    Li, Jia
    Lin, Weihong
    MEDICINE, 2018, 97 (18)
  • [25] Paraneoplastic neurological syndromes associated with ovarian tumors
    Zaborowski, Mikolaj Piotr
    Spaczynski, Marek
    Nowak-Markwitz, Ewa
    Michalak, Slawomir
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (01) : 99 - 108
  • [26] Paraneoplastic neurological syndromes associated with ovarian tumors
    Mikolaj Piotr Zaborowski
    Marek Spaczynski
    Ewa Nowak-Markwitz
    Slawomir Michalak
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 99 - 108
  • [27] A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes
    de Jongste, Adriaan H.
    van Gelder, Teun
    Bromberg, Jacoline E.
    de Graaf, Marieke T.
    Gratama, Jan W.
    Schreurs, Marco W.
    Hooijkaas, Herbert
    Smitt, Peter A. Sillevis
    NEURO-ONCOLOGY, 2015, 17 (01) : 145 - 150
  • [28] Peripheral Nerve Pathology in Antibody Positive Paraneoplastic Neurological Syndromes
    Granger, Andre
    Rajnauth, Tina
    Dubey, Divyanshu
    Mills, John
    Mauermann, Michelle
    Berini, Sarah
    Dyck, P. James B.
    Klein, Christopher
    NEUROLOGY, 2023, 100 (17)
  • [29] SCLC patients with paraneoplastic neurological syndromes and anti-Hu antibodies have reduced counts of circulating cytotoxic T lymphocytes
    de Beukelaar, JW
    Gratama, JW
    Hop, WC
    Hooijkaas, H
    Kraan, J
    Kruger, M
    Vejans, GM
    Smitt, PAS
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 174 (1-2) : 193 - 193
  • [30] No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies
    Janet W. de Beukelaar
    Georges M. Verjans
    Yvette van Norden
    Johannes C. Milikan
    Jaco Kraan
    Herbert Hooijkaas
    Kees Sintnicolaas
    Jan W. Gratama
    Peter A. Sillevis Smitt
    Cancer Immunology, Immunotherapy, 2007, 56 : 1501 - 1506